Prevalence of hyperhomocysteinemia and the MTHFR C677T polymorphism in patients with arterial and venous thrombosis from North Western Russia

Thrombosis Research

Volumn 111, Issue 6, 2003, Pages 351-356

  Shmeleva, Veronika M ^a   Kapustin, Sergey I ^a   Papayan, Ludmila P ^a   Sobczyńska Malefora, Agata ^b   Harrington, Dominic J ^b   Savidge, Geoffrey F ^b  

^a Russian Institute of Haematology and Transfusion   (Russian Federation)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Haemostatic factors; Homocysteine; Hyperhomocysteinemia; Methylenetetrahydrofolate reductase; Peripheral arterial disease; Thrombosis

Indexed keywords

ANTIGEN; BLOOD CLOTTING FACTOR 8; HOMOCYSTEINE;

ADOLESCENT; ADULT; AGED; AMINO ACID BLOOD LEVEL; ANTIGEN EXPRESSION; ARTERY THROMBOSIS; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE FUNCTION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE C677T GENE; PREVALENCE; PRIORITY JOURNAL; RUSSIAN FEDERATION; VEIN THROMBOSIS;

EID: 0348048776     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2003.10.004     Document Type: Article

References (20)

1. Makris M. Hyperhomocysteinemia and thrombosis. Clin. Lab. Haematol. 22:2000;133-143.
2. Cattaneo M. Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb. Haemost. 81:1999;165-176.
3. Brattström L.E., Wilcken D.E.L., Öhrvik J., Brudin L. Common methylene tetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease. The result of a meta-analysis. Circulation. 98:1998;2520-2526.
4. Fiskerstrand Y., Refsum H., Kvalheim G., Ueland P. Homocysteine and other thiols in plasma and urine: automated determination and sample stability. Clin. Chem. 39:1993;263-271.
5. Guba S., Fink L., Fonseca V. Hyperhomocysteinemia an emerging and important risk factor for thromboembolic and cardiovascular disease. Am. J. Clin. Pathol. 105:1996;709-722.
6. Allain J.P., Cooper H.A., Wagner R.H., Brinkhous K.M. Platelets fixed with paraformaldehyde: a new reagent for assay of von Willebrand factor and platelet aggregating factor. J. Lab. Clin. Med. 85:1975;318-328.
7. Ingerslev J.A. A sensitive ELISA for von Willebrand factor (vWF:Ag). Scand. J. Lab. Invest. 47:1987;143-149.
8. Arruda V.R., von Zuben P.M., Chiaparini L.C., Annichino-Bizzacchi H.M., Costa F.F. The mutation Ala677-Val in the methylene tetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis. Thromb. Haemost. 77(5):1997;818-821.
9. Gandrille S., Alhenc-Gelas M., Aiach M. A rapid screening method for the factor V Arg506 to Gln mutation. Blood Coagul. Fibrinolysis. 6(3):1995;245-248.
10. Poort S.R., Rosendaal F.R., Reitsma P.H., Bertina R.M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and increase in venous thrombosis. Blood. 88:1996;3698-3703.
11. Schwartz E.I., Papayan L.P., Baranovskaya S.S., Volkova M.V., Sirotkina O.V., Sheidina A.M.et al. The genetic predisposition to thrombophilia in Russian population. Thromb. Haemost., Suppl. 1999;385. Abstracts XVII Congress of ISTH, Washington.
12. Eichinger S., Stümpflen A., Hirschl M., Bialonczyk C., Herkner K., Stain M.et al. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism. Thromb. Haemost. 80:1998;566-569.
13. Ray J.G. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch. Intern. Med. 158:1998;2101-2106.
14. Gaustadness M., Rüdiger N., Rasmussen K., Ingerslev J. Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants. Thromb. Haemost. 83:2000;554-558.
15. Gudnason V., Stansbie D., Scott J., Bowron A., Nicaud V., Humphries S. C677T (thermolabile alanine/valine) polymorphism in methylenetetrahydrofolate reductase (MTHFR): its frequency and impact on plasma homocysteine concentration in different European populations. Atherosclerosis. 136:1998;347-354.
16. Balasa V.V., Gruppo R.A., Glueck C.J., Becker A., Pillow A., Stroop D.et al. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. Thromb. Haemost. 81:1999;739-744.
17. Guttormsen A.B., Ueland P.M., Nesthus J., Nygård O., Schneede J., Vollset S.E.et al. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (>40 μmol/l). The Hordaland Homocysteine Study. J. Clin. Invest. 98:1996;2174-2183.
18. Sassi S., Cosmi B., Palareti G., Legnani C., Grossi G., Musolesi S.et al. Influence of age, sex and vitamin status on fasting and post-methionine load plasma homocysteine levels. Haematologica. 87:2002;957-964.
19. de Bree A., Verschuren W.M.M., Blom H.J., Kromhout D. Lifestyle factors and plasma homocysteine concentrations in a general population sample. Am. J. Epidemiol. 154:2001;150-154.
20. Vermaak H.W.J., Ubbink J.B., Bamard H.C., Potgieter G., van Jaarsveld H., Groenewald A.J. Vitamin B6 nutrition status and cigarette smoking. Am. J. Clin. Nutr. 51:1990;1058-1061.